Skip to content

Cytokinetics CYTK Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Operating margin-695.4%+2,207pp-2,902.7%+3,687pp-6,589.7%-6,247pp-342.8%-78.2pp
Net margin-891.6%+2,300pp-3,191.1%+3,798pp-6,988.6%-6,577pp-411.2%-105pp
Efficiency
Asset turnover0.1×0.0×0.0×-0.1×0.1×0.0×
Liquidity
Current ratio4.5×-1.6×6.2×0.0×6.1×-3.3×9.4×+1.9×
Per Share
Book value per share-$5.49-354%-$1.21+69.8%-$4.00-233%-$1.20-138%
Valuation
Market capitalization$7.77B+39.9%$5.55B-32.2%$8.19B+88.8%$4.34B+12.7%
Price / sales88.2×-212×300.5×-787×1,087.2×+1,041×45.8×-8.8×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Cytokinetics's ratios come from?
Every ratio is computed from Cytokinetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.